Evaluation of HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1 polymorphisms associated with prostate cancer in samples of patients from HUPE-UERJ

Prostate. 2024 Feb;84(2):166-176. doi: 10.1002/pros.24635. Epub 2023 Oct 15.

Abstract

Purpose: Prostate cancer (PCa) is the leading cause of death among men in 48 countries. Genetic alterations play a significant role in PCa carcinogenesis. For the hypothesis of this research, five unique polymorphisms (SNP) were investigated in different genes that showed to be associated in different ways with PCa: rs4430796, rs2735839, rs4792311, rs12329760, and rs28931588, respectively for the genes HNF1B, KLK3, ELAC2, TMPRSS2-ERG, and CTNNB1.

Patients and methods: Blood samples from 426 subjects were evaluated: 290 controls (161 females and 129 males) and 136 PCa patients. SNP were determined by real-time polymerase chain reaction. TaqMan SNP genotyping assay. In the control samples, the SNPs were defined in association with the self-reported ethnicity, and in 218 control samples with markers with ancestry indicators. The genes were in Hardy-Weinberg equilibrium. One hundred and seventy control samples were matched by ethnicity for comparison with the PCa samples.

Results: The G allele at rs28931588 was monomorphic in both patients and controls studied. Significant differences were observed in allelic and genotypic frequencies between the control and Pca samples in rs2735839 (KLK3; p = 0.002 and χ2 = 8.73 and p = 0.01, respectively), by the global frequency and in the dominant model rs2735839_GG (odds ratio [OR] = 0.51, p = 0.02). AA and GA genotypes at rs4792311 (ELAC2) were more frequent in patients with Gleason 7(4 + 3), 8, and 9 (n = 37%-59.7%) compared to patients with Gleason 6 and 7(3 + 4) (n = 26%-40.0%) conferring a protective effect on the GG genotype (OR = 0.45, p = 0.02). The same genotype showed an OR = 2.71 (p = 0.01) for patients with low severity. The HNF1B-KLK3-ELAC2-TMPRSS2-ERG haplotypes: GAAT, AAAT, GAGT, and AAGT were more frequent in patients with Pca with OR ranging from 4.65 to 2.48.

Conclusions: Higher frequencies of risk alleles were confirmed in the SNPs, KLK3 rs2735839_A, ELAC2 rs4792311_A, and TMPRSS2 rs12329760_T in patients with Pca. Rs2735839_A was associated with risk of Pca and rs4792311_A with severity and Gleason score of 7(4 + 3) or greater. There is a need for careful observation of rs2735839 and rs4792311 in association with the prostatic biopsy due to the increased risk of Pca.

Keywords: ELAC2; KLK3; RT-PCR; SNP; genetic markers; prostatic neoplasms.

MeSH terms

  • Genetic Predisposition to Disease
  • Genotype
  • Hepatocyte Nuclear Factor 1-beta / genetics
  • Humans
  • Kallikreins / genetics
  • Male
  • Neoplasm Proteins
  • Polymorphism, Single Nucleotide
  • Prostate-Specific Antigen*
  • Prostatic Neoplasms* / pathology
  • Transcriptional Regulator ERG / genetics
  • beta Catenin / genetics

Substances

  • Prostate-Specific Antigen
  • Kallikreins
  • ERG protein, human
  • Transcriptional Regulator ERG
  • HNF1B protein, human
  • Hepatocyte Nuclear Factor 1-beta
  • ELAC2 protein, human
  • Neoplasm Proteins
  • CTNNB1 protein, human
  • beta Catenin
  • TMPRSS2 protein, human
  • TMPRSS2-ERG fusion protein, human